CAMBRIDGE, Mass., April 28, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that management will present a company overview at two upcoming investor conferences.
Deutsche Bank 26th Annual Healthcare Conference
10:00 a.m. EDT on May 2, 2011 in Boston, MA
Craig Wheeler, Chief Executive Officer, will be presenting.
Bank of America Merrill Lynch 2011 Healthcare Conference
8:00 a.m. PDT on May 10, 2011 in Las Vegas, NV
Richard Shea, Chief Financial Officer, will be presenting.
A live audio webcast of each presentation will be available on the "Investors" section of the Company's website located at . A replay of each presentation will be available on the Momenta website for 30 days following the event.
About Momenta
Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex mixture drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drug products, as well as to the discovery and development of novel drugs.
To receive additional information about Momenta, please visit the website at , which does not form a part of this press release.
Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.
CONTACT: Beverly Holley Director, Investor Relations Momenta Pharmaceuticals, Inc. bholley@momentapharma.com 617-395-5189